The prospects of a new class of Duchenne muscular dystrophy therapies have taken another downturn after Roche abandoned development of RG6206, a myostatin inhibitor. The Swiss group revealed the ...

The importance of Myostatin is being discussed more frequently in the breeding of the suckler herd in Northern Ireland. This ...